We are live on ! Find out more
Loomis, Sayles & Company

Loomis, Sayles & Company Portfolio holdings

AUM $74.3B
1-Year Est. Return 24.01%
This Fund
S&P 500
This Quarter Est. Return
+13.71%
1 Year Est. Return
+24.01%
3 Year Est. Return
+109.67%
5 Year Est. Return
+145.58%
10 Year Est. Return
+623.12%
AUM
$75.7B
AUM Growth
+$6.94B
Cap. Flow
-$695M
Cap. Flow %
-0.92%
Top 10 Hldgs %
38.84%
Holding
852
New
205
Increased
261
Reduced
298
Closed
58

Top Buys

Rank Stock Value
1
NVS icon
Novartis
NVS
+$840M
2
DIS icon
Walt Disney
DIS
+$492M
3
BA icon
Boeing
BA
+$492M
4
SBUX icon
Starbucks
SBUX
+$276M
5
SLB icon
SLB Ltd
SLB
+$216M

Sector Composition

Rank Sector Weight
1 Technology 26.48%
2 Consumer Discretionary 16.31%
3 Communication Services 13.43%
4 Healthcare 12.88%
5 Industrials 11.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TTGT icon
151
TechTarget
TTGT
$278M
$41.3M 0.05%
698,092
+98,821
+16% +$5.11M
NXPI icon
152
NXP Semiconductors
NXPI
$60.4B
$41.2M 0.05%
259,014
+4,905
+2% +$723K
KAI icon
153
Kadant
KAI
$3.99B
$40.4M 0.05%
286,581
-12,522
-4% -$1.59M
MBUU icon
154
Malibu Boats
MBUU
$567M
$40.3M 0.05%
645,966
+90,410
+16% +$5.22M
PRLB icon
155
Protolabs
PRLB
$2.13B
$40.2M 0.05%
261,959
-1,757
-0.7% -$248K
BPMC
156
DELISTED
Blueprint Medicines
BPMC
$39.9M 0.05%
355,391
-2,097
-0.6% -$221K
EGOV
157
DELISTED
NIC Inc
EGOV
$39.8M 0.05%
1,541,111
-9,001
-0.6% -$209K
YMAB
158
DELISTED
Y-mAbs Therapeutics
YMAB
$38.8M 0.05%
784,282
-4,654
-0.6% -$215K
FIVN icon
159
FIVE9
FIVN
$2.54B
$38.7M 0.05%
221,840
-558,926
-72% -$85M
TCOM icon
160
Trip.com Group
TCOM
$29.1B
$38.2M 0.05%
1,131,770
+27,489
+2% +$896K
PCTY icon
161
Paylocity
PCTY
$7.98B
$38.1M 0.05%
185,253
+22,037
+14% +$4.24M
RMBS icon
162
Rambus
RMBS
$11B
$37.9M 0.05%
2,172,019
-12,811
-0.6% -$201K
ARES icon
163
Ares Management
ARES
$30.9B
$37.6M 0.05%
799,660
+95,088
+13% +$4.3M
HQY icon
164
HealthEquity
HQY
$8.75B
$37.6M 0.05%
539,286
+80,638
+18% +$5.02M
EVTC icon
165
Evertec
EVTC
$1.78B
$37.6M 0.05%
955,266
-5,753
-0.6% -$214K
GNRC icon
166
Generac Holdings
GNRC
$12.5B
$37.4M 0.05%
164,382
-335,791
-67% -$72.3M
MXL icon
167
MaxLinear
MXL
$6.8B
$37.3M 0.05%
+977,730
New +$28.4M
ACA icon
168
Arcosa
ACA
$7.11B
$37.2M 0.05%
676,901
-29,540
-4% -$1.51M
SSTK icon
169
Shutterstock
SSTK
$219M
$37.1M 0.05%
516,913
+39,066
+8% +$2.59M
AXON
170
Axon Enterprise
AXON
$46.4B
$36.8M 0.05%
300,012
+35,532
+13% +$4.08M
HURN icon
171
Huron Consulting
HURN
$2.42B
$36.1M 0.05%
612,633
-3,753
-0.6% -$172K
TRMB icon
172
Trimble
TRMB
$13.9B
$36.1M 0.05%
540,666
+64,445
+14% +$3.7M
BAH icon
173
Booz Allen Hamilton
BAH
$9.15B
$35.8M 0.05%
410,547
-29,121
-7% -$2.48M
DORM icon
174
Dorman Products
DORM
$4.18B
$35.6M 0.05%
409,549
+259,915
+174% +$24.1M
AMK
175
DELISTED
AssetMark Financial Holdings, Inc.
AMK
$35.5M 0.05%
1,467,823
-8,419
-0.6% -$199K

Similar funds

Loomis, Sayles & Company's Q4 2020 Portfolio in Review

As of Q4 2020, Loomis, Sayles & Company held 852 positions worth $75.7B, up 10% from $68.7B the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Loomis, Sayles & Company's Q4 2020 filing shows 205 new, 261 increased, 298 reduced and 58 closed positions. Its largest new stake was TSMC: 1,053,323 shares worth $115M. The largest sale was Varian Medical Systems, Inc., an estimated $442M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 28% a quarter earlier, followed by Consumer Discretionary and Communication Services.

  • Loomis, Sayles & Company's largest Q4 2020 buy was TSMC: 1,053,323 shares worth $115M.
  • Loomis, Sayles & Company added most to Novartis in Q4 2020, an estimated $840M increase.
  • Loomis, Sayles & Company's biggest Q4 2020 reduction was Varian Medical Systems, Inc., cutting an estimated $442M.
  • Loomis, Sayles & Company fully exited Palomar in Q4 2020, selling an estimated $64.4M.
  • Loomis, Sayles & Company's ten largest holdings make up 39% of its $75.7B portfolio in Q4 2020.
  • Loomis, Sayles & Company opened 205 new positions and closed 58 in Q4 2020.
  • Loomis, Sayles & Company's portfolio value rose 10% quarter-over-quarter to $75.7B.

Based on Loomis, Sayles & Company's 13F filing for Q4 2020, filed 12 Feb 2021.